Loading...
Healius Limited
HLS.AX•ASX
Healthcare
Medical - Diagnostics & Research
A$0.74
A$0.00(0.00%)
Healius Limited (HLS.AX) Financial Performance & Statements
Review Healius Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
2.30%
↑ 2.30%
Operating Income Growth
-30.98%
↓ 30.98%
Net Income Growth
-72.40%
↓ 72.40%
Operating Cash Flow Growth
-22.39%
↓ 22.39%
Operating Margin
26.20%
↑ 26.20%
Gross Margin
29.62%
↑ 29.62%
Net Profit Margin
-1.46%
↓ 1.46%
ROE
-2.21%
↓ 2.21%
ROIC
18.06%
↑ 18.06%
Healius Limited (HLS.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Healius Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $897.20M | $849.00M | $842.80M | $864.10M |
| Cost of Revenue | $619.50M | $705.10M | $673.30M | $691.90M |
| Gross Profit | $277.70M | $143.90M | $169.50M | $172.20M |
| Gross Profit Ratio | $0.31 | $0.17 | $0.20 | $0.20 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $30.10M | $128.20M | $114.00M | $132.80M |
| Operating Expenses | $30.10M | $128.20M | $114.00M | $132.80M |
| Total Costs & Expenses | $649.60M | $833.30M | $787.30M | $824.70M |
| Interest Income | $0.00 | $0.00 | $0.00 | $28.50M |
| Interest Expense | $34.80M | $36.00M | $33.80M | $28.50M |
| Depreciation & Amortization | $20.50M | $143.40M | $140.40M | $136.80M |
| EBITDA | $70.30M | $159.10M | -$181.40M | $176.20M |
| EBITDA Ratio | $0.08 | $0.19 | $0.23 | $0.20 |
| Operating Income | $247.60M | $15.70M | $55.50M | $39.40M |
| Operating Income Ratio | $0.28 | $0.02 | $0.07 | $0.05 |
| Other Income/Expenses (Net) | -$258.10M | -$655.30M | -$411.10M | -$81.10M |
| Income Before Tax | -$10.50M | -$639.60M | -$355.60M | -$41.70M |
| Income Before Tax Ratio | -$0.01 | -$0.75 | -$0.42 | -$0.05 |
| Income Tax Expense | -$4.50M | -$9.60M | -$1.50M | -$15.80M |
| Net Income | -$10.00M | -$635.80M | -$345.90M | -$28.70M |
| Net Income Ratio | -$0.01 | -$0.75 | -$0.41 | -$0.03 |
| EPS | -$0.009 | -$1.07 | -$0.56 | -$0.05 |
| Diluted EPS | -$0.01 | -$1.07 | -$0.56 | -$0.05 |
| Weighted Avg Shares Outstanding | $1.18B | $594.21M | $615.32M | $615.29M |
| Weighted Avg Shares Outstanding (Diluted) | $725.39M | $594.21M | $615.32M | $615.29M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan